Published in
Elsevier, Clinical Breast Cancer, 2(19), p. 137-145.e4, 2019
DOI: 10.1016/j.clbc.2018.11.009
Links
Tools
A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study
Journal article published in 2019 by
Sara Gagno 
,
Mario Rosario D’Andrea,
Mauro Mansutti,
Chiara Zanusso,
Fabio Puglisi ,
Eva Dreussi,
Marcella Montico,
Paola Biason ,
Erika Cecchin,
Donatella Iacono,
Stefania Russo,
Marika Cinausero,
Silvana Saracchini,
Giampietro Gasparini,
Donata Sartori
and other authors.
,
Mario Rosario D’Andrea,
Mauro Mansutti,
Chiara Zanusso,
Fabio Puglisi ,
Eva Dreussi,
Marcella Montico,
Paola Biason ,
Erika Cecchin,
Donatella Iacono,
Stefania Russo,
Marika Cinausero,
Silvana Saracchini,
Giampietro Gasparini,
Donata Sartori
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 